Akshay Vaishnaw
Director/Board Member chez SCHOLAR ROCK HOLDING CORPORATION
Fortune : 4 M $ au 31/03/2024
Profil
Le Dr Akshay K. Vaishnaw est directeur indépendant de Scholar Rock Holding Corp. et d'Editas Medicine, Inc. et président de la recherche et du développement d'Alnylam Pharmaceuticals, Inc. et membre du Royal College of Physicians. Il siège au conseil d'administration de Scholar Rock Holding Corp, Scholar Rock, Inc. et Editas Medicine, Inc. Le Dr Vaishnaw était auparavant employé par Biogen Idec, Inc. en tant que directeur principal de la médecine translationnelle. Il a également siégé au conseil d'administration de Visterra, Inc. Il a obtenu son diplôme de premier cycle à l'université de Cardiff, un doctorat à la faculté de médecine de l'université de Cardiff et un doctorat à l'université de Londres.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/08/2023 | 23 289 ( 0,02% ) | 3 M $ | 31/03/2024 | |
| 21/06/2023 | 9 455 ( 0,01% ) | 167 921 $ | 31/03/2024 | |
EDITAS MEDICINE, INC.
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Akshay Vaishnaw
| Sociétés | Poste | Début |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/10/2023 |
| EDITAS MEDICINE, INC. | Director/Board Member | 28/07/2016 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 21/05/2019 |
| The Royal College of Physicians | Corporate Officer/Principal | 07/07/2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 01/05/2019 |
Anciens postes connus de Akshay Vaishnaw
| Sociétés | Poste | Fin |
|---|---|---|
| VISTERRA INC | Director/Board Member | 01/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Formation de Akshay Vaishnaw
| University of London | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
